Cornerstone Capital Management Holdings’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,900	Closed	-$177K	–	1451
2016 Q3	$177K	Buy	3,900 +300	+8%	+$12K	﹤0.01%	1206
2016 Q2	$144K	Sell	3,600 -400	-10%	-$14.6K	﹤0.01%	1242
2016 Q1	$139K	Buy	4,000 +400	+11%	+$14.7K	﹤0.01%	1271
2015 Q4	$155K	Buy	+3,600	New	+$180K	﹤0.01%	1255
2015 Q1	–	Sell	-2,400	Closed	-$93K	–	1449
2014 Q4	$93K	Sell	2,400 -4,700	-66%	-$179K	﹤0.01%	1168
2014 Q3	$251K	Buy	+7,100	New	+$208K	﹤0.01%	1071

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Cornerstone Capital Management Holdings's BSTC Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2016, closing a stake of 3,900 shares — an estimated $177K sold.

Cornerstone Capital Management Holdings first reported a position in BSTC in Q3 2014 and held it in 6 quarters. The position peaked at $251K in Q3 2014. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining BioSpecifics Technologies Corp. position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 3,900 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $177K.
Cornerstone Capital Management Holdings first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 6 quarters.
Cornerstone Capital Management Holdings's BioSpecifics Technologies Corp. position peaked at $251K in Q3 2014.
96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.